Skip to main content
Clinical Trials/CTRI/2020/11/028826
CTRI/2020/11/028826
Active, not recruiting
未知

Effect of anaesthetic agents on immuno-inflammatory response of breast cancer

Chittaranjan National Cancer Institute0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C50- Malignant neoplasm of breast
Sponsor
Chittaranjan National Cancer Institute
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Newly diagnosed breast cancer (Unilateral) confirmed with histopathological diagnosis. 2\. ASA I (Normal healthy patient) \& ASA II (Patient with mild systemic disease)
  • 3\. T1 N0, T2N0, T3N0, T1N1, T2N1, T3N1 Mx
  • 4\. Both male \& female
  • 6\. Duration of surgery \<\= to 2 hrs.

Exclusion Criteria

  • 1\. Patient having any kind of anticancer treatment
  • 2\. Active bleeding
  • 3\. Recent history of massive blood transfusion
  • 4\. Pregnant \& Lactating woman

Outcomes

Primary Outcomes

Not specified

Similar Trials